Emactuzumab Uses, Dosage, Side Effects and more
Emactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Emactuzumab |
| Generic | Emactuzumab |
| Emactuzumab Other Names | Emactuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
